Nicki Panoskaltsis, MD PhD FRCP
Professor in Personalised Therapeutics
School of Pharmacy & Pharmaceutical Sciences
Trinity Translational Medicine Institute
Trinity College Dublin
panoskan@tcd.ie
Education
1987-1989: Biochemistry / Genetics, The University of Western Ontario, London Canada.
1989-1993: M.D., The University of Toronto, School of Medicine, Toronto Canada.
1993-1996: Residency in Internal Medicine, Strong Memorial Hospital, The University of Rochester, Rochester NY USA.
1996-1999: Fellowship in Hematology & Bone Marrow Transplantation, Strong Memorial Hospital, The University of Rochester, Rochester NY USA.
1999-2003: Ph.D. (Immunology), The University of London, Imperial College London, UK
Biography
Professor Panoskaltsis is a clinician-scientist with a niche interest in translational interdisciplinary research and personalised therapeutics, focused in myeloid neoplasms. She completed her MD at the University of Toronto (Canada), clinical training and American Board Certification in Internal Medicine, Haematology and Bone Marrow Transplantation at the University of Rochester (USA) and a PhD in Immunology at Imperial College London (UK) where she remained as faculty until 2018. She has recently moved from Emory University and Georgia Institute of Technology (USA) and is now Professor in Personalised Therapeutics at Trinity College Dublin, Consultant Haematologist at St. James’s Hospital and an Adjunct Principal Investigator at NIBRT. She has an international reputation in cytokine release syndrome, in using bio-inspired three-dimensional (3D) ex vivo models to study normal and malignant hematopoiesis, and in creating novel precision immune-chemotherapeutics using mathematical modeling and ex vivo 3D perfusion bioreactor culture systems. She is a Fellow of the Royal College of Physicians (London), has received numerous awards for excellence in clinical care, research, entrepreneurship, and has several patents.
Research Interests
Cytokine release syndrome
Immune pathogenesis of acute myeloid leukemia
Myeloid neoplasm biology
Human hematopoietic organoids & 3D culture systems
Personalised therapeutics
In silico modeling of immuno-chemotherapy